Results 191 to 200 of about 374,223 (267)

Presencia de anticuerpos anti virus hepatitis E en pacientes con infección aguda por virus hepatitis A [PDF]

Natalia Covarrubías, Julio Miranda, Caterina Chesta, Mauricio Venegas, Carmen Hurtado   +4 more
openalex   +1 more source

Safety, tolerability and pharmacokinetics of DNDI‐6148, a novel agent for leishmaniasis: A randomized, controlled, single ascending dose study in healthy participants

British Journal of Clinical Pharmacology, EarlyView.
Aim The benzoxaborole derivative DNDI‐6148 is an antiparasitic agent with activity against multiple Leishmania protozoan species, including L. infantum and L. donovani, which cause visceral leishmaniasis. We investigated the safety, tolerability and pharmacokinetics of single oral doses of DNDI‐6148 in a randomized, parallel‐group, placebo‐controlled ...
Jean‐Yves Gillon, Sophie Delhomme, Delphine Launay, Séverine Blesson, Stéphanie Braillard, Pegah Maghdooni, Frauke Assmus, Richard Hoglund, Joel Tarning, Sabrina Loyau, Byron Arana, Mathilde Latreille‐Barbier, Yves Donazzolo   +12 more
wiley   +1 more source

HEVnet: a One Health, collaborative, interdisciplinary network and sequence data repository for enhanced hepatitis E virus molecular typing, characterisation and epidemiological investigations [PDF]

, 2019
Annemieke Christine Mulder, Annelies Kroneman, Eelco Franz, Harry Vennema, Anna D. Tulen, Johanna Takkinen, Agnetha Hofhuis, Cornelia Adlhoch, Members of HEVnet   +8 more
openalex   +1 more source

Long‐term impact of Elexacaftor/Tezacaftor/ivacaftor on pulmonary, nutritional and metabolic outcomes in homozygous F508del cystic fibrosis patients: A real‐world cohort study

British Journal of Clinical Pharmacology, EarlyView.
Aim Elexacaftor/tezacaftor/ivacaftor (ETI) has markedly improved cystic fibrosis (CF) outcomes. However, its long‐term impact on nutrition, metabolism and liver health remains underexplored. We assessed 30‐month changes in pulmonary, nutritional, metabolic and inflammatory markers in people with CF (PwCF) homozygous for F508del.
Nicola Perrotta, Luigi Angelo Fiorito, Roberta Vescovo, Anna Virgilio, Giulia Amato, Giuseppe Cimino   +5 more
wiley   +1 more source

Hepatitis E in the pediatric population: An overlooked disease but a genuine concern? [PDF]

Clin Exp Hepatol
Janczura J, Jończyk K, Nowak K, Choromański T, Pawliński J, Starnawski P, Woynarowski M.   +6 more
europepmc   +1 more source

Epidemiological and virological characteristics of 10 cases of sporadic acute hepatitis E from Tokyo and Kanagawa

, 2005
Masahiro Arai, Naoaki Hashimoto, Hiroshi Miyakawa, Takayuki Abe, T. Yamanaka, Michihiko Shibata, Natsuki Abe, Kazuaki Takahashi, Shunji Mishiro   +8 more
openalex   +2 more sources

Long–Term Response to Hepatitis B Vaccination and Response to Booster in Children Born to Mothers With Hepatitis B E Antigen [PDF]

, 1999
Li‐Min Huang, Bor‐Luen Chiang, Chin‐Yun Lee, Ping‐Ing Lee, Wei‐Kuang Chi, Mei‐Hwei Chang   +5 more
openalex   +1 more source

Infection Risk From Humans and Animals in the Anatomy Laboratory: A Scoping Review

Clinical Anatomy, EarlyView.
ABSTRACT Whole‐body dissection is a cornerstone of anatomy education. During and following the COVID‐19 pandemic, exposure to infectious agents and other risks of dissection were highlighted. To identify potential risks, one must have the data outlining these risks in specific situations.
Margaret A. McNulty, Elizabeth R. Agosto
wiley   +1 more source

Hepatitis E Virus Infection in Brazil: A Scoping Review of Epidemiological Features. [PDF]

Pathogens
Mariz CA, de Araújo LRMG, Lopes EP.
europepmc   +1 more source

Hepatitis E Virus A Potential Threat to Pregnancy

, 2014
Rosy Sultana
openalex   +2 more sources